Vaccines for Prevention of Malaria
Abstract
This effort selects candidate vaccines for various types of malaria, including the severe form of malaria (Plasmodium falciparum) and the less severe but relapsing form (Plasmodium vivax), prepares technical data packages required for FDA approval of testing in humans and conducts testing of promising malaria vaccine candidates in humans. A malaria vaccine would minimize the progression and impact of drug resistance and poor Warfighter compliance with taking preventive anti-malarial drugs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2016
- Source ID
- 02c20f14a722f05c2039dd2520e5a8fe